Tutis Pharmaceuticals Private Limited
About Tutis Pharmaceuticals Private Limited
Data last updated:
Tutis Pharmaceuticals Private Limited was a private limited company based in Kozhikode, Kerala, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trade segment of the trading and commerce sector. It was incorporated on 07 June 2010.
The company was registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52311KL2010PTC026152.
The company had an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1.14 Lakh. It was led by directors Vijayaraghavan Karumathil (Managing Director) and Arjun Vasanth.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at 4/1225 – A Opposite Lions Park Beach Road, Kozhikode, Kerala, India – 673032.
As per the financials filed for FY 2020, the company reported a revenue of ₹47,148, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹36,669 (net margin -77.8%) and EBITDA of -₹79,700 (EBITDA margin -169%). Revenue has declined at a compounded annual rate (CAGR) of 58% over three years and 38% over five years.
Company details
Contact details
Tutis Pharmaceuticals Private Limited's registered office is in Kozhikode, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4/1225 – A Opposite Lions Park Beach Road, Kozhikode, Kerala, India – 673032
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Tutis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tutis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tutis Pharmaceuticals Private Limited, buy the company report.
Financials of Tutis Pharmaceuticals Private Limited
FY 2020 filings availableTutis Pharmaceuticals Private Limited reported revenue of ₹47,148 (down 84% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 38% over five years, including a 84% fall in the latest year. EBITDA fell 341% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹79,700 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹36,669 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -169% | ||||
| Net Profit Margin | -77.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tutis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tutis Pharmaceuticals Private Limited
Tutis Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Vasanth | Director | 12 Dec 2012 | 13 Years 10 Months | As last reported |
| Vijayaraghavan Karumathil | Managing Director | 07 Jun 2010 | 16 Years 5 Months | As last reported |
Auditor
Tutis Pharmaceuticals Private Limited is audited by AVF & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVF & ASSOCIATES | FY 2017 | 228776 |
Shareholding
The shareholding of Tutis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Tutis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tutis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tutis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tutis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tutis Pharmaceuticals Private Limited has 9 board changes on record since 2010: 2 appointments and 7 cessations. The latest: Rajendran Madhavan Nair ceased to be Director on 14 Sep 2018.
Frequently asked questions
Tutis Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Tutis Pharmaceuticals was a private limited company based in Kozhikode, Kerala, India. The company worked in retailers, within the trading industry. It was incorporated on 07 June 2010 and is registered under CIN U52311KL2010PTC026152. The company has been struck off by the Registrar of Companies and is no longer operational.
Tutis Pharmaceuticals had 2 directors:
- Vijayaraghavan Karumathil - Managing Director
- Arjun Vasanth - Director
The CIN (Corporate Identification Number) of Tutis Pharmaceuticals is U52311KL2010PTC026152. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Tutis Pharmaceuticals is at 41225 – A Opposite Lions Park Beach Road, Kozhikode, Kerala, India – 673032.
Tutis Pharmaceuticals was incorporated on 07 June 2010. It is registered with the Registrar of Companies, Ernakulam.
The latest financial statements of Tutis Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
Tutis Pharmaceuticals operated in the trading industry, in the retailers segment. It worked in this industry before it was struck off.
Rajendran Madhavan Nair ceased to be Director on 14 Sep 2018. Santosh Kumar ceased to be Director on 14 Sep 2018. Sonny Arakkal Thomas ceased to be Director on 14 Sep 2018. Tutis Pharmaceuticals has 9 board changes on record in total.
The compliance status of Tutis Pharmaceuticals is compliant as of 02 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
